MEI Pharma http://investor.meipharma.com/ MEI Pharma Reports Fiscal Year 2018 Results and Operational Highlights http://investor.meipharma.com/2018-08-30-MEI-Pharma-Reports-Fiscal-Year-2018-Results-and-Operational-Highlights -Fiscal Year 2018 Highlighted by Progress Across All Four Clinical-stage Oncology Candidates; ME-401 Accelerated Approval Study to Start by Year-end 2018- Thu, 30 Aug 2018 13:05:00 -0700 http://investor.meipharma.com/2018-08-30-MEI-Pharma-Reports-Fiscal-Year-2018-Results-and-Operational-Highlights MEI Pharma To Present at Wells Fargo Securities 2018 Healthcare Conference http://investor.meipharma.com/2018-08-29-MEI-Pharma-To-Present-at-Wells-Fargo-Securities-2018-Healthcare-Conference Wed, 29 Aug 2018 05:00:00 -0700 http://investor.meipharma.com/2018-08-29-MEI-Pharma-To-Present-at-Wells-Fargo-Securities-2018-Healthcare-Conference MEI Pharma to Release 2018 Fiscal Year End Financial Results and Provide Corporate Update on August 30, 2018 http://investor.meipharma.com/2018-08-23-MEI-Pharma-to-Release-2018-Fiscal-Year-End-Financial-Results-and-Provide-Corporate-Update-on-August-30-2018 Thu, 23 Aug 2018 05:00:00 -0700 http://investor.meipharma.com/2018-08-23-MEI-Pharma-to-Release-2018-Fiscal-Year-End-Financial-Results-and-Provide-Corporate-Update-on-August-30-2018 MEI Pharma Promotes David M. Urso to Chief Operating Officer http://investor.meipharma.com/2018-07-16-MEI-Pharma-Promotes-David-M-Urso-to-Chief-Operating-Officer Mon, 16 Jul 2018 05:00:00 -0700 http://investor.meipharma.com/2018-07-16-MEI-Pharma-Promotes-David-M-Urso-to-Chief-Operating-Officer MEI Pharma Presents Clinical Data on ME-401 at the European Hematology Association Congress http://investor.meipharma.com/2018-06-15-MEI-Pharma-Presents-Clinical-Data-on-ME-401-at-the-European-Hematology-Association-Congress --Initiation of registration study for ME-401 in patients with relapsed or refractory follicular lymphoma expected before year-end-- Fri, 15 Jun 2018 05:00:00 -0700 http://investor.meipharma.com/2018-06-15-MEI-Pharma-Presents-Clinical-Data-on-ME-401-at-the-European-Hematology-Association-Congress